search
global health
Trends
- 1UN Holds Second High-Level Meeting on Pandemic Preparedness●Second United Nations General Assembly High‑Level Meeting on Pandemic Prevention, Preparedness and Response
The United Nations General Assembly is convening its second High-Level Meeting on Pandemic Prevention, Preparedness and Response, with the World Health Organization among the participating bodies. The meeting is expected to review global progress since the first session and discuss how countries can better coordinate on early warning systems, equity in vaccines and treatments, and financing for future health emergencies.
- 2US rejects UN pandemic preparedness declaration, blocking consensus●US rejects UN pandemic preparedness declaration, blocking consensus adoption
The United States has rejected a United Nations declaration on pandemic preparedness, preventing its adoption by consensus. The move blocks a unified international statement on coordinating responses to future global health emergencies. Details on the US objections and possible next steps at the UN remain limited as outlets pick up the story.
- 3US and EU reject UN pandemic collaboration treaty▼US, EU reject UN General Assembly internation pandemic collaboration treaty
The United States and European Union have rejected a UN General Assembly resolution backing an international pandemic collaboration treaty. The move undermines efforts to create a binding global framework for coordinating responses to future health emergencies. Critics of the treaty have raised concerns over national sovereignty, while public health advocates argue global cooperation is essential to prevent a repeat of the COVID-19 crisis.
- 4European capital to help Colombian biotech firm produce 250 million vaccines●Europe Injects Capital into Colombian Biotech Firm to Produce 250 Million Vaccines
A Colombian biotechnology company has received European investment to expand vaccine production, with plans to manufacture up to 250 million doses. The deal reflects Europe's push to strengthen global vaccine supply chains and Latin America's growing role in pharmaceutical manufacturing. Details on the investors and timelines have not yet been widely reported.